Some Quality Measures reporting has changed for 2018 reporting in Year 2 MIPS

Recently, we became aware of a few differences in the Quality reporting codes for Year 2 MIPS (2018).  Some of these changes affect Quality Measures reporting codes that were commonly used in 2017.  Under Year 2 MIPS, Quality is reported for a full year, so it is vitally important for those reporting via claims to be aware of the changes.  Registry reports are affected as well, but since reporting for registries does not take place until early 2019, the urgency is not the same.  All 2018 Resources, including the Quality measure specifications sheets, can be accessed at this link.  The Measures that changed and affect eye providers are as follows.

 Measure 14:  Age-Related Macular Degeneration (AMD): Dilated Macular Exam

  • A common code for 2017 (2019F) is no longer active
  • For 2018 there are new codes:
    • Use G9974 when performance is met
      • There is no longer the option to use 1P, 2P, or 8P modifiers with this code
    • Use G9975, G9892, G9893 when performance is not met
    • “Unspecified Eye” diagnosis codes are no longer applicable

Measure 130Documentation of Current Medications in the Medical Record

  • CPT code 99024 (post-operative visit) is now included for the 2018 reporting year
  • Note: This only affects providers in groups of 10 or more providers in the following states, who should already be reporting 99024 on post-operative visits via claims:
    • FL, KY, LA, NV, NJ, ND, OH, OR, and RI

Measure 226Preventive Care and Screening:  Tobacco Use:  Screening and Cessation Intervention

  • The new specifications sheet notes there are now 3 submission criteria (a change from 2017):
    1. % patients age 18+ screened for tobacco use 1/more times within 24 months
    2. % patients age 18+ screened for tobacco use AND identified as a tobacco user who received tobacco cessation intervention
    3. % patients age 18+ screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
  • Providers must report on ALL applicable criteria (1, 2 and 3)

IMPORTANT:  Because of the above changes, Measure 226 appears to be VERY difficult to report successfully and make a high score.  Practices may want to consider NOT DOING this measure in 2018.

We are happy to assist providers and groups in any way.  Please contact us via one of the below or on our “App”, Corcoran 24/7, which can be accessed via one of the links below.   (800) 399-6565


Website by MIC